Evotec SE has entered into a five-year partnership with the Bill & Melinda Gates Foundation to discover new treatment regimens that better address tuberculosis (TB), a severe global health threat and one of the leading causes of death due to infectious diseases worldwide. Evotec will receive a grant of approximately $23.8 million for a five-year period to generate standardized, high-quality preclinical data to support novel regimen selection and development.   The current standard treat...